4-1BBL (ATCC® 68682)

Depositors: Immunex Corporation, JB Oster, Immunex Corporation

Permits and Restrictions

View Permits

Designations 4-1BBL
U.S. Patent
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Depositors Immunex Corporation, JB Oster, Immunex Corporation
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Vector Information
Construct size (kb): 7.199999809265137
The plasmid pDC201 was assembled from (1)the SV40 origin of replication, enhancerand early and late promoters; (2)the adenovirus-2 major late promoter and tripartite leader; (3)adeenovirus-2-virus-associated RNA genes (VAI/VAII) and, (4)pMSLV.
(5)SV40 polyadenylation and transcription termination signals. Restriction digests of the clone give the following sizes (kb): BamHI--3.8,2.5,0.63,0.3; PstI--7.0; XhoI--6.0,0.56.
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Growth Conditions
Temperature: 37.0°C

Goodwin RA, et al. Cytokine designated 4-1BB ligand. US Patent 5,674,704 dated Oct 7 1997

Shipped freeze-dried
Shipping Information Distributed: freeze-dried